Immunotherapy with hymenoptera venom in a child with anaphylaxis

Authors

  • Inês Falcão Department of Allergy and Clinical Immunology, Centro Hospitalar Universitário do Porto
  • Leonor Cunha Department of Allergy and Clinical Immunology, Centro Hospitalar Universitário do Porto

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v30.i2.19718

Keywords:

anaphylaxis, child, hymenoptera, immunotherapy

Abstract

Systemic reactions to hymenoptera venom in childhood are uncommon, comprising less than 1% of cases. The prevalence proves higher in adults, encompassing 0.3−8.9%. Anaphylaxis forms the most severe of all allergic reactions and can be fatal. Specific immunotherapy based on hymenoptera venom is the only treatment that prevents moderate-to-severe systemic reactions. Due to immunotherapy safety and effectiveness, this treatment is indicated during childhood in cases of grade II and III systemic reactions.

The authors describe the clinical case of a fourteen-year-old male patient, son of a beekeeper, who was followed in the Allergy and Clinical Immunology Department due to anaphylaxis to hymenoptera venom and was under immunotherapy to Apis mellifera venom since the age of nine, besides complying with measures to evade hymenoptera.

References

Schiener M, Graessel A, Ollert M, Schmidt-Weber CB, Blank S. Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis. Human Vaccines & Immunotherapeutics. 2017; 13:2467-81.https://doi.org/10.1080/21645515.2017.1334745.

Pitchon R, Pitchon dos Reis A, Gomes Silva G, Zogheib J, Pitchon dos Reis D. Hymenoptera venom allergy: outpatient aspects and urgency. Revista Médica de Minas Gerais. 2014; 24:S6-S12. https://doi.org/10.5935/2238-3182.20140033.

Elisa Pedro M. Alergia ao veneno de Himenópteros. Alergia e o Clínico Geral. Rev. Port. Imunoalergol. 1999; 7:191-4.

Reisman RE, Livingston A. Venom immunotherapy: 10 years of experience with administration of single venoms and 50g maintenance doses. J Allergy Clin Immunol. 1992; 89:1189-95.

Muller UR, Johansen N, Petersen AB, Fromberg-Nielsen J, Haerberli G. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and ves v5. Allergy. 2009; 64:543-8. https://doi.org/10.1111/j.1398-9995.2008.01794.x.

Santos S, Loureiro CC, Lemos S, Pinheiro JA. Alergia a veneno de himenópteros na criança. Scientia Medica (Porto Alegre). 2012; 22:203-7.

Golden DB, Marsh DG, Kagey-Sobotka A, Freidhoff L, Szklo M, Valentine MD, et al. Epidemiology of insect venom sensitivity. JAMA. 1989, 262:240-4.

Pesek RD, Lockey Richard F. Management of Insect Sting Hypersensitivity: An Update. Allergy Asthma Immunol Res. 2013; 5:129-37.

Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilò MB, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. First published: 27 July 2017. https://doi.org/10.1111/all.13262.

Krishna MT, Ewan PW, Durham SR, Frew AJ, Leech SC, Nasser AM. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 2011; 41:1201-20.

Ponvert C. Quoi de neuf en allergologie pédiatrique en 2013? Épidemiologie générale, diagnostic (précoce), traitement, anaphylaxie, allergie alimentaire, medicamenteuse et aux venins et salives d’insects (une revue de la literature internationale 2013). Rev Fr Allergol. 2014; 54:397-419.

Golden DBK, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 2004; 351:668-74.

Downloads

Published

2021-06-30

How to Cite

Falcão, I., & Cunha, L. (2021). Immunotherapy with hymenoptera venom in a child with anaphylaxis. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL, 30(2), 114–118. https://doi.org/10.25753/BirthGrowthMJ.v30.i2.19718

Issue

Section

Case Reports

Most read articles by the same author(s)